Shimizu T, Krebs S, Bauersachs S, Blum H, Wolf E, Miyamoto A. Actions and interactions of progesterone and estrogen on transcriptome profiles of the bovine endometrium. Physiol Genomics 42A: 290 -300, 2010. First published September 28, 2010; doi:10.1152/physiolgenomics.00107.2010.-The aim of our study was to analyze endometrial gene expression profiles in ovariectomized cows treated with estradiol and/or progesterone by using microarray analysis. Clustering of differentially expressed genes allowed separation into distinct hormone response patterns. These patterns could be classified into independent and interdependent actions of the steroid hormones estrogen and progesterone. The use of ovariectomized cows and external administration of hormones identified a set of genes whose regulation depends on a progesterone priming effect. The progesterone-primed estrogen response comprises gene functions such as migration, cell differentiation, and cell adhesion and therefore may play a crucial role in tissue remodeling, as one of its key regulators in the endometrium, TGFB2, is among this group of progesterone-primed genes. Functional annotation analysis of the estrogen-responsive gene clusters shows a clear dominance of functions such as cell cycle, morphogenesis, and differentiation. The functional profile of the progesterone-responsive clusters is less clear but nevertheless shows some important fertility-related terms like luteinization, oocyte maturation, and catecholamine metabolism. We looked for putative regulators of the steroid hormone response in endometrium by searching for enriched transcription factor binding sites in the promoter regions of the genes with similar hormone response profile. This analysis identified transcription factors such as SP1, NFYA, FOXA2, IRF2, ESR1, and NOBOX as candidate regulators of gene expression in bovine endometrium treated with steroid hormones. Taken together, our data provide novel insights into the regulation of bovine endometrial physiology by steroid hormones.
cow; steroid hormone THE DECLINING FERTILITY in dairy cows has resulted in much attention to elucidation of the underlying causes of poor conception rates. The establishment of pregnancy requires numerous, precisely timed interactions that occur between the ovary (corpus luteum), oviduct, endometrium, and embryo (50, 53) . In addition, inappropriately timed signals may result in poor embryonic development and subsequent pregnancy failure (9) . A large proportion of embryonic losses occur before maternal recognition of pregnancy (15, 21) . A correlation between concentrations of progesterone (P 4 ) and pregnancy rates has been observed both in beef and dairy cattle (14) . The blastocyst develops with the formation of the blastocoel surrounded by the trophectoderm, and in this window P 4 is likely to have its greatest influence on the development of the embryo (33) . In fact, P 4 supplementation in cattle increased embryo size on day 14 of pregnancy (17) .
The endometrium is responsible for the secretion of numerous cytokines, growth factors, and proteins that are collectively termed the histotroph. The histotroph is secreted from the glandular epithelium in the endometrium into the lumen of the uterus. Changes in mRNA expression profiles in bovine endometrium during the estrous cycle were already evaluated in two studies (7, 36) . Microarray studies that give an insight into the changes occurring in gene expression in the endometrium during the sexual cycle have been performed also in humans (19) , mice (26) , sheep (12) , and pigs (44) . In cattle, two studies (8, 28) have taken two different animal model approaches to address the differences in endometrial gene expression between pregnant and cycling animals on day 18. To evaluate the specific effects of steroid hormones on gene expression profiles in the endometrium we analyzed ovariectomized cows after treatment with either estradiol (E 2 ) or P 4 alone or in combination, using Affymetrix GeneChip Bovine Genome Arrays.
MATERIALS AND METHODS
Animal treatment and tissue collection. All experiments were conducted at the Field Center of Animal Science and Agriculture, Obihiro University, and all experimental procedures complied with the Guidelines for the Care and Use of Agricultural Animals of Obihiro University. Animal experimental procedures were approved by the Institutional Animal Care and Use Committee of Obihiro University (no. [18] [19] [20] [21] [22] [23] [24] [25] . Twelve Holstein cows (3-7 yr of age) that had been ovariectomized 40 -50 days before the beginning of the experiment were maintained in a free-stall barn throughout the experimental period and had free access to food and water. Ovariectomized cows (n ϭ 12) were randomly divided into four groups: the control group (n ϭ 3) received saline treatment at day 0 (beginning of the experiment); E 2 groups (n ϭ 3) received 1 mg of estradiol benzoate (EB) at day 5; two controlled internal drug release devices (CIDRs) (Pfizer, Tokyo, Japan) were inserted into the vagina of animals of the P 4 group (n ϭ 3) from day 0 to day 6 to enhance the plasma concentration of P 4 to the levels of typical midluteal phase; and the E2ϩP4 group (n ϭ 3) received two CIDRs at day 0 and 1 mg of EB immediately after removal of the CIDRs at day 6. A timeline of blood and tissue samples is shown in Fig. 1 . To determine plasma E 2 and P4 levels during the experiment blood samples were collected every day, starting 1 day before CIDR insertion, with sterile 10-ml tubes containing 200 l of stabilizer solution (0.3 M EDTA, 1% acetyl salicylic acid, pH 7.4). All animals were killed 2 days after final blood sampling as shown in Fig.  1 , and the endometrium (intercaruncular) was collected as described previously (7) . The tissue samples were snap frozen and stored at Ϫ80°C until analysis.
Hormone assays. Determination of the plasma P 4 concentration was performed by enzyme immunoassay (EIA) after diethyl ether extraction as described previously (37) ; the extraction efficiency was 90%. The standard curve ranged from 0.05 to 50 ng/ml, and the 50% effective dose (ED 50) of the assay was 3.1 ng/ml. The intra-and interassay coefficients of variation (CVs) averaged 7.4% and 8.7%, respectively.
Determination of the plasma E 2 concentration was performed by EIA after diethyl ether extraction as described previously (2); the extraction efficiency was 78%. The standard curve ranged from 1.95 to 2,000 pg/ml, and the ED 50 of the assay was 18.1 pg/ml. The intraand interassay CVs averaged 9.0% and 10.4%, respectively.
RNA isolation and microarray hybridization. For isolation of total RNA a piece of deep-frozen tissue was transferred to 5 ml of RNAlater-ICE (Ambion, Austin, TX) and allowed to impregnate at Ϫ20°C over 2 days for optimal RNA protection. The impregnated tissue sample was transferred to 5 ml of TRIzol reagent (Invitrogen, Carlsbad, CA) and immediately crushed with a tissue homogenizer (Heidolph, Schwabach, Germany). The homogenate was processed according to the TRIzol method (manufacturer's protocol) to yield highly pure total RNA that was checked by spectrophotometry (Nanodrop ND-100, NanoDrop Technologies, Wilmington, DE) for assessment of purity and by agarose gel electrophoresis for assessment of RNA integrity.
Labeled cRNA probes for array hybridization were prepared with the Ambion Message Amp Biotin enhanced kit (Ambion). Briefly, 1 g of total RNA was reverse transcribed to cDNA, which was then in vitro transcribed with biotin-labeled UTP to yield biotinylated cRNA. Ten micrograms of fragmented cRNA was hybridized overnight to Affymetrix bovine 3=-IVT GeneChips (Affymetrix, Santa Clara, CA), processed in an Affymetrix Fluidics Station 450, and scanned with the Affymetrix 3000 7G scanner. The statistics software R and packages from the Bioconductor microarray suite (affy, affyPLM, QualityControlMetrics) were used for processing the CEL files and to check for consistent quality. The microarray data were deposited in the GEO database under the accession number GSE 16880.
Microarray data analysis. Arrays were summarized and normalized with the robust multiarray average (RMA) method, and noise signals were filtered out using the MAS5 present calls. Differentially expressed genes were identified with R package LIMMA (47) . Thresholds were set at a false discovery rate (FDR) of 1% and fold change Ն2. The resulting list of differentially expressed genes was subjected to cluster analysis with the MeV4.2 program package. For clustering the expression values were converted to deviations from the mean of all arrays, and the Pearson correlation was chosen as clustering metric. Clustering algorithms SOTA, CAST, and SOM were used to identify clusters of coexpressed genes. General enrichment trends were determined with GSEA, and enriched annotations for specific clusters were identified with CoPub (16). Transcription A: plasma concentration of P4 in control (n ϭ 3), E2 (n ϭ 3), P4 (n ϭ 3), and E2ϩP4 (n ϭ 3) groups. B: plasma concentration of E2 in control (n ϭ 3), E2 (n ϭ 3), P4 (n ϭ 3), and E2ϩP4 (n ϭ 3) groups. Ovariectomy was performed on all animals 40 -50 days before the beginning of the experiment. The procedure for blood sampling is described in MATERIALS AND METHODS. E2, estradiol; P4, progesterone; EB, estradiol benzoate; CIDR, controlled internal drug-releasing device.
factor binding sites were scored for enrichment with the oPOSSUM program (18) .
Real time RT-PCR. Quantitative real-time PCR reactions were performed with the same RNA samples as used for microarray hybridization with Fast SYBR Green Master Mix on a StepOne instrument (both from Applied Biosystems, Carlsbad, CA). The following primers were designed to amplify specific fragments of selected differentially expressed genes (length of the PCR products in base pairs): BAX (205 bp; for 5=-TCTGACGGCAACTTCAACTG-3=, rev 5=-TGGGTGTCCCAAAGTAGGAG-3=), FST (149 bp; for 5=-CAGTGCCTGTCACCTGAGAA-3=, rev 5=-CCTCTGCCAACCTT-GAAGTC-3=), HPGD (80 bp; for 5=-TCTGTCTTCCACTGTAATGCT-CAAAGC-3=, rev 5=-AGTGAAGGCCACCAGTACAAAGACT-3=), INHBA (113 bp; for 5=-CGATGGGCAGAACATCATC-3=, rev 5=-GTCTTCTTTGGACCGTCTCG-3=), KLF5 (100 bp; for 5=-GCTATAT-GCTGGCTTGACCC-3=, rev 5=-GGAAGAACACTGCAAGCACA-3=), PENK (142 bp; for 5=-TCTGGAATGTGAGGGGAAAC-3=, rev 5=-CTTCTTAGCAAGCAGGTGGC-3=), PTHLH (148 bp; for 5=-TCCCCTAACTCCAAGCCTGC-3=, rev 5=-TTTTCTTTTTCTTGC-CGGG-3=), TRIB3 (157 bp; for 5=-GGGCTCTAGGGTCCTGAATC-3=, rev 5=-ATCCACTCGTGCTGATACCC-3=), and SF3A1 (84 bp; for 5=-ACAAGGGTCCAGTGTCCATC-3=, rev 5=-AGACCAGCACCT-GTCCATTC-3=) as housekeeping gene. All amplified PCR fragments were sequenced (3100-Avant Genetic Analyzer; Applied Biosystems) to verify the identity of the assayed gene. In addition, melting curve analysis at the end of each real-time measurement confirmed purity and identity of the amplified product. Each qPCR reaction was carried out with a cDNA amount equivalent to 50 ng of total RNA in a total reaction volume of 20 l and 2 pmol of each primer. The annealing temperature was 60°C for all PCRs. To obtain the cycle threshold (C T) difference, the data were analyzed with the ⌬⌬CT method, with ⌬CT ϭ CTtarget Ϫ CTreference SF3A1 and ⌬⌬CT ϭ mean ⌬CT of treatment group Ϫ mean ⌬CT of control group.
RESULTS
Plasma P 4 and E 2 concentrations. The mean concentration of plasma P 4 during insertion of 2 CIDRs showed high physiological levels (4 -8 ng/ml) and then declined after removal of CIDRs ( Fig. 2A) . The mean concentration of plasma E 2 was rapidly increased after injection of EB (Fig. 2B) .
Gene expression. Statistical analysis of the microarray experiments resulted in 291 differentially expressed genes for the comparison of control versus P 4 treatment, 721 for control versus E 2 treatment, and 689 for control versus sequential P 4 /E 2 treatment. There was ϳ50% overlap between the E 2 single treatment and the combined P 4 /E 2 treatment and little overlap of these two groups with the progesterone treatment group (Fig. 3 ). It is remarkable that for P 4 there were very few downregulated genes (Fig. 4B) , while for the estrogen treatment induction and repression of gene expression were more balanced (Fig. 4 , A and C). Principal component analysis (PCA; Fig. 5 ) showed that along the first axis the P 4 and E 2 groups were clearly separated from the control groups and that P 4 and E 2 had opposite effects. It also is evident that the combination treatment largely resembles the E 2 effect; however, this effect is intensified as this group is shifted further to the right, contrary to the P 4 effect. Thus it is already perceivable that the response of the endometrium to combined administration of the two hormones does not simply reflect the net effect of individual E 2 and P 4 treatments, but rather documents a functional interaction between the two hormones, making the response to estrogen even stronger when the endometrium has experienced a pretreatment with P 4 . The second principal component does not separate the different hormones but seems to represent general response to hormone treatment. Cluster analysis. The results of the cluster analysis are represented in Fig. 6 , showing the relative expression changes, and in Table 1 , listing the gene symbols assigned to the probe sets in the clusters. Grouping of the differentially expressed genes into clusters of coexpressed genes allows the description of different hormone response patterns. In general, we observed patterns of independent and interdependent hormone actions. Genes that respond exclusively to E 2 are aggregated in clusters 1 and 3 (Fig. 6 ). These genes are not affected by progesterone and show no difference between the single E 2 treatment and the combined E 2 ϩ P 4 treatment. The genes in cluster 5 are regulated only by P 4 . However, in the combined treatment the P 4 effect is not seen. This might be due to the E 2 effect, which counteracts the progesterone action, or due to the time shift between the P 4 and E 2 ϩP 4 samples. The fact that estrogen can counteract the P 4 effect is seen in cluster 2, whose genes are downregulated by estrogen and upregulated by P 4 . In the P 4 pretreatment group the expression level is even lower than with single E 2 treatment, so there is interaction between the two hormones. There are more such interaction patterns with slightly different characteristics. Clusters 4 and 6 comprise estrogen-responsive genes whose reaction is amplified by P 4 priming. Clusters 8 and 10 respond to P 4 , whose effect is reversed by subsequent E 2 treatment. Interestingly, these genes do not respond to E 2 alone. So estrogen action is not amplified as in clusters 4 and 6, but the genes are rather made receptive for the estrogen stimulus by P 4 . This kind of sensitization is also seen in cluster 9 but, however, without a significant effect of P 4 treatment alone. For the genes in cluster 7 the P 4 action seems to persist with neither an effect of the subsequent E 2 administration nor an effect of the longer time shift between P 4 withdrawal and sampling. Finally, cluster 11 represents genes that show a generic response to steroid hormones, regardless of the nature of the hormone or the treatment scheme.
Functional annotation. To get a clearer picture of the processes that are influenced by the different hormone response patterns identified in the cluster analysis, the constituent gene lists were subjected to enrichment analyses of functional an- Table 1 . Genes in clusters presented in Figure 6 representing different hormone response patterns
Cluster
Gene Symbols 1  8D6A, AAAS, AADAT, ABAT, ACAT2, ADAM12, ADAM9, ADAMTS2, ADAMTS4, AF1Q, AGC1, AGTR1, AMIGO3, AP1S2, AP3S1,  APEX1, ARF3, ARFGAP1, ARFGAP3, ARL1, ARMET, ARSB, ATAD3A, ATP2A2, ATP6V0D1, ATP6V1A, B4GALT7, B7H3,  BACH, BAX, BDH, BHLHB5, BM039 , C10orf32, C10orf58, C11orf24, C14orf1, C14orf37, C16orf33, C19orf10, C19orf4, C20orf139, C20orf59, C21orf62, C21orf66, C3F, C9orf16, C9orf19, CALR, CALU, CCNB1, CCNC, CCT6A, CD164L1 , CDR2, CGI-111, CGREF1,  CHCHD3, CHSY1, CKAP4, CNIH, CNNM2, COL15A1, COL1A1, COL1A2, COL2A1, COL4A1, COL5A2, COL6A3, COPE, COPZ1,  COPZ2, CPSF6, CPXM, CRABP2, CRTAP, CSPG4, CXCL2, DC2, DCTD, DFFA, DHCR24, DHDH, DKKL1, DNAJC10, DNAJC3,  DNM3, DPP3, EIF4A1, EMID1, EMILIN1, EMP3, ENDOG, ENTPD1, ERP70, ETF1, ETHE1, FADS1, FAM46A, FBLN5, FDFT1,  FKBP10, FKBP11, FKBP14, FKBP7, FLJ10134, FLJ10292, FLJ10534, FLJ14490, FLJ20364, FLJ32810, FLJ46365, FMOD, FUT4,  FXYD7, FZD2, G6PC3, GARS, GBE1, GCNT3, GFAP, GFPT1, GLB1, GLRX2, GLT25D1, GLTP, GMPPA, GMPPB, GPR133, GPX3,  GPX7, GREB1, GUSB, HCN4, HDAC2, HDLBP, HGF, HM13, HMBS, HMGB3, HMGCS1, HN1, HNMT, HSD11B1, HSPA5, HTPAP,  HYAL2, HYOU1, IFNAR1, IGFBP6, IGSF1, IKIP, ILF3, IMPA3, INHBA, INSIG1, ITGA5, ITPR2, KCNE1, KDELR3, KIAA0152 , SLC11A2, SLC15A1, SLC16A11, SLC18A2, SLC25A10, SLC30A10, SNPH, SPINT2, SSX2IP, ST14,  STARD4, SYPL, SYVN1, TACR3, TCF2, TCFL4, TGFB1I4, TJP2, TJP3, TM4SF11, TM4SF2, TMC4, TMEM30B, TP53INP1, TST,  TTC12, UGT1A6, UNQ541, USP32, USP43, VIL2, WDR19, WDR22, ZDHHC23, ZNF339, ZZANK1  3 ABCC9, ABTB1, ACAD10, ACOX2, ADAM33, ADAMDEC1, ADHFE1, AK3L1, AKAP12, ALDH1A1, ALDH1A3, AMY2B, ANG, ANGPT4, ANKRD23, APOD, AQP9, ARG99, AUH, BACH2, BCL2, BTBD3, C10orf10, C10orf38, C20orf36, C20orf82, C9orf150, C9orf26 , C9orf94, CABC1, CBX7, CD7, CDK3, CEACAM1, CG018, CHR3SYT, CHRDL1, CLK4, CNNM3, CNOT1, CNTNAP4,  CRY2, CSTF3, CTSF, CUL3, CXorf45, CYFIP2, CYP2J2, CYP4B1, DCC, DDHD2, DHRS8, DLG2, DST, EBF, ECH1, EFHA2,  EPB41L5, EZH1, FAM49A, FAS, FBXO32, FBXO44, FGF10, FGL1, FGL2, FLJ13639, FLJ20457, FLJ32745, FLJ40773, FLJ42200,  FLJ43965, FLJ45645, FOXP1, FZD8, GAB1, GABARAPL1, GDAP1, GFRA4, GLS, GNG12, GPC3, GPD1, GPRC5B, GPX2, GSTK1,  GSTM3, GTF2B, HELZ, HEXA, HLF, HNRPR, HSD17B12, HTR3C, IGFBP3, ILKAP, IQSEC1, ISLR, KIAA0408, KIAA0650,  KIAA0853, KIAA1536, KLF15, KLHDC3, LGALS9, LOC118430, LOC126731, LOC285086, LOC285331, LOC90826, LSP1, LTBP4,  LY6G5B, MAMDC2, MAP3K3, MFNG, MGC17330, MGC40368, MGC45780, MGC45840, MGC5618, MGEA5, MGP, MLLT7,  MUSTN1, MXI1, MYCBP2, MYOZ2, NFASC, NFAT5, NGFB, NKIRAS1, NR1D1, NR3C2, NR4A2, NT5E, OGFRL1, OSR2, PCAF,  PER2, PHF15, PLXDC2, PNRC1, PPM1D, PRKD3, PROCA1, PXMP2, RAB30, RAPH1, RASAL1, RASSF2, RGS9, RNASE4, RNF39,  RPA2, RPRM, RPS6KA5, RPS6KB1, S100A13, SDPR, SE57-1, SELENBP1, SESTD1, SGNE1, SH3TC2, SIAT9, SLC25A28,  SLCO2B1, SLCO3A1, SR140, SSBP2, SYCP3, TBC1D7, TENC1, TGFBR3, TIMP4, TOM1L2, TRAF5, TRIM7, TSC1, TTC7B, TU3A,  TXNIP, TXNRD1, ULK2, VNN1, WDR27, YPEL3, ZBTB4, ZC3HDC6, ZDHHC1, ZDHHC2, ZNF418, ZZEF1  4 ADRA2C, ALDOC, AMPH, ANLN, ANXA6, AOC3, ASNA1, ASPM, ASPN, AURKB, BUB1, C10orf9, C18orf4, C1QTNF1 , C20orf70,  CCBE1, CCNB2, CD109, CD44, CDCA5, CDCA8, CDT1, CENPA, CHPF, CHRNA3, CHST7, CKAP2, CKLFSF3, CKLFSF4, CNTFR,  COL12A1, COL14A1, COL6A2, COMP, CRHR1, CTPS, CTSK, CUTL1, CXCL12, CXCL14, CYGB, DCAMKL1, DDT, DHDH,  DTNA, EDNRA, EPB41L1, EPOR, ERCC1, ETV2, FBXO32, FGF2, FLJ10156, FLJ12505, FLJ12610, FLJ20160, FLJ20272, FLJ20512,  FLJ23311, FLJ35880, FN1, FOLR1, FOXP2, GALK1, GALT, GBA, GENX-3414, GJA7, GNA14, GNG2, H2AFY2, HOXA10, HSPB6,  HTRA4, IGFBP5, IQGAP3, ITGA8, ITSN1, JAM3, KCNA2, KCNJ8, KIAA0101, KIAA0143, KIAA1128, KIAA1576, KIF20A, KIF2C,  KIFC1, KNTC2, LAMC1, LGALS1, LHFPL3, LHPP, LOC150368, LOC387914, LOC441631, LOC90139, LPHN2, LXN, MAPK4, ME1,  ME3, MFAP5, MGC13204, MGC4093, MKI67, MMD, MMP14, NOL3, NOV, NUDT11, NUSAP1, OIP5, OLR1, PARVB, PBX1,  PCGF2, PDLIM7, PFKM, PGM1, PGR, PIP5K2A, PLD3, PLXDC2, PPARGC1A, PRC1, PRKCDBP, PRKRA, PRSS35, PTTG1,  PVRL3, RAB15, RAM2, RASA3, RASL11B, RBM9, RBMS2, RBPMS, RCN1, RIMS1, RND3, ROBO2, RRAS, RRM2, RTN2, SBBI54,  SCGF, SDC3, SH3BGR, SHCBP1, SIAT7C, SIAT7F, SLC35D1, SLC39A6, SSR4, STK38L, SULT1B1, TEAD1, TGFB1I1, TOP2A,  TPM1, TPP1, TRPC4, TSRC1, TUWD12, UBE2C, UHRF1, UXT, WDFY1, WTIP, YWHAG, ZDHHC14 notation terms (gene ontologies) that were linked to genes by automated text mining of PubMed abstracts (Fig. 7) . Most of the clusters have functional profiles that clearly separate them from the other clusters, indicating that this approach can indeed retrieve biological relationships. The estrogen-responsive clusters show a clear dominance of functions like cell cycle, morphogenesis, and differentiation. The functional profile of the progesterone-responsive clusters is less clear. Interestingly, the term "decidualization" lights up among the estrogen-responsive genes, although this process does not occur in cattle. However, the genes that were assigned to this term comprise genes that are downregulated upon decidualization of primate endometrium (IGFBP5, FN1, HOXA10 , MKI67, and PGR). Transcription factors. The promoter regions of genes in coexpressed clusters were searched for enrichment of conserved transcription factor binding sites by the program oPOSSUM (18) . There was a significant enrichment for nuclear transcription factor Y, ␣ (NFYA) targets in cluster 11 ( Table 2) . NFYA has been reported to be involved in the steroid-dependent regulation of sterol and fatty acid biosynthesis (27, 39, 56) . Interestingly, sterol and fatty acid biosynthesis are the predominant annotation terms of cluster 11. In a cluster of estrogen-regulated genes binding sites of myeloid zinc finger 1 (MZF1) and specificity protein 1 (SP1) were enriched together with those for estrogen receptor (ER)␣. These three transcription factors might play a common role in mediating the transcriptional response to estrogen.
Various forkhead transcription factors are significantly enriched in cluster 3 (Table 2 ), which aggregates genes that are downregulated by estrogen. An enrichment of forkhead motifs has recently been reported for promoter regions bound by ER␣, but not for those bound by ER␤ (32) . Thus it can be concluded that the repressive effect of estrogen observed for the genes in cluster 3 is mainly exerted by ER␣. For the genes in cluster 6, which are also downregulated by estrogen but in contrast to cluster 3 with an amplified response when primed with P 4 , such a preference for ER subtype is not seen. In contrast, SP1 is enriched in cluster 1 and in cluster 12 (a subgroup of cluster 1) ( Table 2 ). SP1 is found preferentially in combination with ER␤ rather than with ER␣ (32). Thus from our data it can be concluded that the usage of ER␣ and ER␤ is not uniform but can vary coinciding with the clustering of expression values, i.e., the two receptors differ in their regulatory actions. Cluster 6 has a significant enrichment of NOBOX (newborn ovary homeobox) binding sites ( Table 2) . qPCR validation. For verification of the microarray results, a set of eight genes was chosen to be validated by qPCR. Table 3 shows the results of real-time PCR of these eight genes together with the respective microarray data. There is a high concordance between qPCR and microarray results; with one exception, all the significant expression changes of the microarray hybridization are also significant in the qPCR assays. The effect of estrogen on the transcript level of PENK (proenkephalin) points in opposite directions as determined by microarray or qPCR, while the effect of P 4 is consistent with both methods. A detailed look at the interrogation positions of both the microarray and the real-time PCR shows that these do not overlap but detect different parts of exon 3 (see Fig. 8 ). Furthermore, the decreased transcript level of the estrogen treatment group is only evident in the last five probes of the Affymetrix probe set, which are closest to the end of the 3=-untranslated region (UTR).
DISCUSSION
This experiment clearly showed that CIDR implant and EB treatment in ovariectomized cows affect subsequent concentration of P 4 and E 2 in blood. These steroid hormone treatments mimic endocrine conditions of the bovine estrous cycle such as the luteal phase (high progesterone) or follicular phase (low progesterone and high estradiol). Ovarian steroids are involved in the regulation of uterine prostaglandin (PG) secretion in cattle (49) . These steroids appear to regulate the endometrial responsiveness to oxytocin and other regulatory factors. P 4 stimulates basal PGF 2␣ production by bovine endometrial cells (3). E 2 amplified the stimulatory effects of P 4 and oxytocin on endometrial PGF 2␣ synthesis, whereas E 2 alone had no effect on PGF 2␣ secretion by bovine endometrial tissue in short-term culture (46) . E 2 stimulated both basal and oxytocin-regulated PGF 2␣ secretion in ovariectomized P 4 -primed cows (6) . These data have demonstrated that E 2 did not stimulate PGF 2␣ release by bovine endometrium without P 4 pretreatment. Therefore P 4 priming is necessary to induce the responsiveness of the bovine uterus to E 2 . Thus we use bovine uterus exposed to P 4 and E 2 to avail physiological descriptions of the bovine endometrial transcriptome. Our data provide a holistic transcriptome analysis in an experimental setup with ovariectomized cows that allows a separate examination of the two main hormonal effectors, estrogen and P 4 . Furthermore, we provide an interesting starting point of the P 4 priming effect of the estrogen response by comparing the effects of single hormone treatments with that of sequentially combined treatment with P 4 followed by estrogen.
Cluster analysis revealed different reaction patterns, allowing us to further dissect the P 4 priming effect into three response classes: 1) an amplification of the estrogen response, 2) a persistence of P 4 action despite the presence of estrogen, and 3) an estrogen response for which P 4 priming is essential. The genes of the first group belong to functional categories of cell cycle, cell division, cell proliferation, developmental processes, and migration. Genes that respond to estrogen without showing a P 4 priming effect display similar functions but also have some additional features like angiogenesis, secretion, and extracellular matrix (ECM). Genes of the third group, showing a response to estrogen only when the endometrium was primed by P 4 , belong to functional categories of morphogenesis, migration, and cell adhesion. Importantly, this group includes TGFB2, which is a main regulator of morphogenesis and Fig. 7 . Enriched functional categories. The genes constituting the clusters in Fig. 6 were subjected to enrichment analysis using the CoPub keyword enrichment calculator. Key words that were significantly enriched (adjusted P value Ͻ0.01) in at least 1 cluster are shown as a heat map. P values are color coded by white for nonsignificant results and by red colors saturating with increasing significance. Rows indicate the enriched terms and columns the P values of the respective clusters. Some terms with a large overlap with others were omitted for clarity. Letters below the cluster assignment describe the kind of hormone response: E, E2; P, P4; E/P, presence of a P4 priming effect.
differentiation, immunoregulation, cell adhesion, and ECM (5) . From the overlap of functional annotations and the inclusion of the TGFB2 expression profile it can be concluded that this group (cluster 10 in Fig. 6 ) is regulated by TGFB2. Thus the TGFB2 response depends on P 4 priming. Interestingly, TGFBs play crucial roles in cycling endometrium as well as in embryo implantation (24) . In addition, a previous report confirmed involvement of the TGFB signaling pathway in regulation of ECM remodeling in bovine endometrium during estrus (7) . Therefore, our data suggested that TGFB signaling induced by P 4 contributes to the regulation of uterine environment.
The significant assignment of functional categories to clusters of genes with similar expression patterns indicates that they form coherent groups with dedicated functions. Such functional units are often controlled by the same factors and thus encourage the search for common transcriptional regulators among these coexpressed genes. We found the binding sites of several transcription factors such as SP1, NFYA, forkhead box A2 (FOXA2), ER␣, and NOBOX to be enriched in the promoter regions of differentially expressed genes of bovine endometrium treated with steroid hormones. These putative regulators may help to establish a hierarchy in the complex hormone-induced changes in gene expression that take place in the endometrium during the estrous cycle and in embryo implantation. NFY is one of the most abundant transcription factors in eukaryotes, and it specifically recognizes the CCAAT box located in the promoters of genes (34) . NFY is a ubiquitous heteromeric transcription factor composed of three subunits, NFYA, NFYB, and NFYC, all necessary for DNA binding (34) . Activation of CDC25A expression by E 2 through activation of the genomic estrogen receptor ER␣/SP1 and E2F1 and cAMP-dependent activation of NFYA have been described in ZR-75 breast cancer cells (45) . Interestingly, cooperative ER␣/SP1/NFY interactions are required for hormone activation in MCF-7 cells (52) . Therefore, this interaction may exist in bovine endometrium, because we detect enrichment of NFY and SP1 binding sites in the same cluster of potentially coregulated genes.
The FOXA group of the forkhead family consists of three genes, designated as FOXA1 (HNF3A), FOXA2 (HNF3B), and FOXA3 (HNF3G). The FOXA proteins were first identified in liver nuclear extracts as transcription factors essential for the regulation of hepatocyte-specific expression of several target genes (30) . Genes for Foxa1 and Foxa2 expressed in the mouse endometrium and uterine glands (10) and E 2 have been shown to upregulate the expression of Foxa2 mRNA at concentrations of 0.1-10 nM (20) . Therefore, our data suggest that estrogen may regulate the action of Foxa family transcription factors also in bovine uterus, which then regulates a great number of downstream targets as indicated by the observed enrichment of transcription factor binding sites.
Human and mouse NOBOX genes are preferentially expressed in oocytes and encode a homeobox transcriptional regulator (22, 51) . The disruption of the murine Nobox gene eliminates the expression of other key oocyte-specific genes including genes regulating the essential processes of genomic imprinting (Dnmt1o) and the maternal-to-zygotic transition (Zar1) among others (41) . This transcription factor plays an important role in folliculogenesis, and defects in this gene lead to premature ovarian failure (41) . Nobox can therefore be classed alongside Fig␣ (Factor in the germ line ␣) (31, 48) as one of the master transcription factors regulating oogenesis, although their roles within the process are distinct. Although there are no reports that Nobox is expressed in the uterus, and the transcript is not interrogated by the microarray used in this study, this factor may be involved in regulation of transcription in bovine uterus.
The transcriptional repressor interferon regulatory factor 2 (IRF2) is found as an enriched transcription factor binding site in cluster 6 that contains genes that are downregulated by estrogen. IRF2 was reported to be induced by the pregnancy recognition signal IFNT and to inhibit luteolysis by suppression of ER␣ and oxytocin receptor (OTXR) in sheep (50) . IRF2 is also regulated during the estrous cycle in sheep (13) . Here its regulation during the estrous cycle is suggested by the detection of the corresponding transcription factor binding site, although the factor itself shows no differential expression.
Steroid hormone receptors in the stromal cells of endometrium and its disease counterpart tissue endometriosis play critical physiological roles. Development and progression of endometriosis depends on the presence of estrogen (4, 11) . However, the biological influence of estrogen on target organs is modulated by changes in tissue hormone levels and the local distribution of its receptors ESR1 (a new name for estrogen receptor ␣) and ESR2 (a new name for estrogen receptor ␤). Studies in knockout mice and its nonidentical tissue distribution compared with ESR1 suggest that ESR2 has a biological function distinct from that of ESR1 (29) . Here we observe enrichment of transcription factors that are differentially associated with ESR1 and ESR2 in separate clusters, also indicating separate roles for the two receptor subtypes: the ESR1-associated transcription factors of the FOX family (32) are found in progesterone-primed clusters, whereas SP1 that is preferentially associated with ESR2 is enriched in estrogenonly clusters. Therefore the priming interaction of P 4 and estrogen in the endometrium seems to be subtype specific and is mediated by the ESR1 receptor. In the uterus, P 4 is known to negatively regulate the expression of ESR1, and P 4 withdrawal results in an induction of ESR1 expression (38, 55) . In pregnant sheep P 4 alone upregulated cervical ESR1 mRNA, and E 2 stimulated ESR1 mRNA expression only after sufficient P 4 priming (54). Moreover, IRF2, expressed in cluster 6 in this study, is a transcriptional repressor and described to be involved in repression of ESR1 and OXTR in the luminal epithelium in response to interferon- (25) . Thus the previous data and our results suggest that tissue-and cell type-specific regulations are an important mechanism in directing responses of different tissues to steroid hormones.
Most of the above conclusions rely on multiple changes of transcript levels, making an interpretation based on measurement artifacts quite unlikely. As a further validation selected differentially expressed genes were tested by real-time RT-PCR to confirm the microarray data. All tested genes were confirmed as differentially expressed. The results for PENK (proenkephalin), however, show some interesting details. While the upregulation by P 4 is confirmed, there is an apparent contradiction in the findings of microarray and qPCR for the estrogen effect. The microarray data show a significant decrease of the PENK transcript relative to the untreated controls, while qPCR indicates an increase. In the physiological estrous cycle of the cow high levels of proenkephalin have been reported during diestrus (7), consistent with the upregulation by P 4 observed here. Upregulation of PENK during estrus has been described for primates (1, 42) , but so far no suppression has been reported. In the rat positive regulation by both estrogen and P 4 has been proposed (43) . A detailed inspection of the hybridization results based on individual probes of the Affymetrix probe set for PENK reveals that the significant decrease of the transcript level is confined to the very 3=-end of the transcript (Fig. 8) . This suggests the existence of alternative transcripts rather than up-or downregulation under the control of either P 4 or estrogen. Two forms of PENK, one induced by P 4 and one induced by estrogen, might also explain in a quite simple fashion the divergent regulatory patterns described for different mammals. For some of the genes validated by realtime PCR regulation during the estrous cycle has already been reported, thus also providing the possibility of evaluating the physiological relevance of this experimental setting with ovariectomized cows. 15-Hydroxyprostaglandin dehydrogenase (HPGD) was reported to peak during diestrus in bovine endometrium, at both the transcript (7) and protein (40) levels, consistent with the P 4 regulation reported here. The regulation of inhibin ␤A (INHBA), Kruppel-like factor 5 (KLF5), and parathyroid hormone-like hormone (PTHLH) is also confirmed in cycling bovine endometrium (7, 36) . Tribbles homolog 3 (TRIB3) and follistatin (FST) have so far not been reported in bovine endometrium studies, but steroid response patterns that are consistent with our observations were reported in other species (23, 35) .
In conclusion, our data provide significant information for uterine physiology after steroid treatment. In E 2 treatment, since gene expression in endometrium may be changed by several estradiols such as estradiol valerate and diethylstilbestrol (34a, 52a) or different plasma concentrations of E 2 after treatment, future study might need to examine these effects on the gene expression of endometrium. The observations of the present study support a critical role for the local production and action of regulatory factors to mediate the cell-cell interactions essential for endometrium function. 
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